Literature DB >> 17178567

Systems biology in systemic lupus erythematosus: integrating genes, biology and immune function.

Vasileios C Kyttaris1, Sandeep Krishnan, George C Tsokos.   

Abstract

Overactive B cells, abnormally activated T cells and inappropriate handling of cellular debris by the innate immune system are central in the pathogenesis of systemic lupus erythematosus (SLE). Genetic studies in SLE patients have unraveled allelic variations in genes encoding key molecules that control inter- and intra-cellular signaling and play a role in the abnormal handling of apoptotic material. Despite recent breakthroughs though, it is still unclear how exactly genes and environment interact to produce the characteristic immune dysregulation in SLE.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17178567     DOI: 10.1080/08916930601061363

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  18 in total

1.  Oxidative stress and endosome recycling are complementary mechanisms reorganizing the T-cell receptor signaling complex in SLE.

Authors:  Andras Perl
Journal:  Clin Immunol       Date:  2011-12-30       Impact factor: 3.969

2.  A T cell gene expression panel for the diagnosis and monitoring of disease activity in patients with systemic lupus erythematosus.

Authors:  Alexandros P Grammatikos; Vasileios C Kyttaris; Katalin Kis-Toth; Lisa M Fitzgerald; Amy Devlin; Michele D Finnell; George C Tsokos
Journal:  Clin Immunol       Date:  2013-12-16       Impact factor: 3.969

Review 3.  Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment.

Authors:  Andras Perl
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

4.  Pathogenic mechanisms in systemic lupus erythematosus.

Authors:  Andras Perl
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

5.  The in vitro treatment with vitamin D3 is ineffective on the expression of PKC isoenzymes, but decreases further the impaired production of IL-2 in the T lymphocytes of SLE patients.

Authors:  Gabriella Czifra; Balázs Tóth; Ildikó Kovács; Tamás Bíró; Zoltán Griger; Sándor Baráth; Tünde Tarr; Margit Zeher; Sándor Sipka
Journal:  Rheumatol Int       Date:  2013-04-24       Impact factor: 2.631

6.  Systemic lupus erythaematosus in a multiethnic US cohort (LUMINA) LIII: disease expression and outcome in acute onset lupus.

Authors:  A M Bertoli; L M Vilá; J D Reveille; G S Alarcón
Journal:  Ann Rheum Dis       Date:  2007-08-24       Impact factor: 19.103

Review 7.  Neuropsychological impairment in systemic lupus erythematosus: a comparison with multiple sclerosis.

Authors:  R H B Benedict; J L Shucard; R Zivadinov; D W Shucard
Journal:  Neuropsychol Rev       Date:  2008-06-03       Impact factor: 7.444

8.  Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation.

Authors:  David R Fernandez; Tiffany Telarico; Eduardo Bonilla; Qing Li; Sanjay Banerjee; Frank A Middleton; Paul E Phillips; Mary K Crow; Stefanie Oess; Werner Muller-Esterl; Andras Perl
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

9.  The IRF5 polymorphism in type 1 diabetes.

Authors:  Hui-Qi Qu; Luc Marchand; Rosemary Grabs; Constantin Polychronakos
Journal:  J Med Genet       Date:  2007-06-08       Impact factor: 6.318

Review 10.  Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjogren's syndrome.

Authors:  Andras Perl
Journal:  Curr Opin Rheumatol       Date:  2009-09       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.